|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.560 CNY | -1.39% |
|
-1.93% | -10.55% |
| Market Cap | 2.79B 414M 358M 334M 307M 580M 39.33B 586M 3.92B 1.54B 19.68B 1.55B 1.52B 65.17B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.01B 446M 386M 360M 331M 625M 42.39B 632M 4.23B 1.66B 21.21B 1.67B 1.64B 70.24B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.39% | ||
| 1 week | -1.93% | ||
| 1 month | +11.25% | ||
| 3 months | -12.10% | ||
| 6 months | -12.32% | ||
| Current year | -10.55% |
| 1 week | 3.43 |  | 3.68 |
| 1 month | 3.07 | | 3.82 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | -1.93% | -21.41% | -33.71% | 419M | |
| +4.11% | -4.07% | +51.55% | +155.63% | 995B | |
| +1.12% | -2.70% | +51.31% | +49.25% | 614B | |
| +0.46% | -6.97% | +23.37% | +62.94% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.70% | 353B | |
| -0.11% | -4.07% | +30.37% | +38.52% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.56% | 245B | |
| +3.44% | +3.78% | +34.06% | +59.05% | 210B | |
| -4.32% | -12.94% | -3.79% | -46.07% | 210B | |
| -2.95% | -1.15% | +16.66% | +62.64% | 168B | |
| Average | +0.54% | -4.38% | +23.22% | +39.65% | 351.87B | |
| Weighted average by Cap. | +1.66% | -5.89% | +36.32% | +71.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 322M 279M 260M 239M 451M 30.62B 456M 3.06B 1.2B 15.32B 1.21B 1.18B 50.74B | 1.86B 276M 239M 223M 205M 387M 26.24B 391M 2.62B 1.03B 13.13B 1.04B 1.01B 43.48B |
| Net income | -317M -46.99M -40.7M -37.94M -34.89M -65.87M -4.47B -66.6M -446M -175M -2.24B -176M -173M -7.4B | -330M -48.82M -42.28M -39.41M -36.25M -68.43M -4.64B -69.2M -463M -182M -2.32B -183M -179M -7.69B |
| Net Debt | 411M 60.86M 52.71M 49.14M 45.19M 85.32M 5.79B 86.27M 577M 227M 2.9B 229M 224M 9.59B | 217M 32.16M 27.85M 25.96M 23.88M 45.08M 3.06B 45.59M 305M 120M 1.53B 121M 118M 5.07B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
Aug. 21
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | CN¥3.560 | -1.39% | 24,169,330 |
| 26-08-04 | CN¥3.610 | +1.12% | 27,164,400 |
| 26-08-03 | CN¥3.570 | +0.28% | 23,264,200 |
| 26-07-31 | CN¥3.560 | +1.42% | 27,276,854 |
| 26-07-30 | CN¥3.510 | -2.77% | 40,269,163 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
